{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:51:11Z","timestamp":1792057871032,"version":"4.4.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1097\/cco.0b013e3282fad846","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T01:24:54Z","timestamp":1264555494000},"page":"264-269","source":"Crossref","is-referenced-by-count":56,"title":["Advances in nasopharyngeal carcinoma"],"prefix":"10.1097","volume":"20","author":[{"given":"Jo\u00ebl","family":"Guigay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/cncr.11485","article-title":"Treatment outcome after radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma","volume":"98","author":"Chua","year":"2003","journal-title":"Cancer"},{"key":"R2-5-20210128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.cco.0000156197.29872.8e","article-title":"Advances in nasopharyngeal carcinoma","volume":"17","author":"O'Meara","year":"2005","journal-title":"Curr Opin Oncol"},{"issue":"Suppl 10","key":"R3-5-20210128","doi-asserted-by":"crossref","first-page":"x304","DOI":"10.1093\/annonc\/mdl278","article-title":"Nasopharyngeal carcinoma and therapeutic management: the place of chemotherapy","volume":"17","author":"Guigay","year":"2006","journal-title":"Ann Oncol"},{"key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0936-6555(03)00201-2","article-title":"Timing of chemotherapy and patient selection for locally advanced nasopharyngeal carcinoma","volume":"15","author":"Sanguineti","year":"2003","journal-title":"Clin Oncol"},{"key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hed.20189","article-title":"Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns","volume":"27","author":"Leung","year":"2005","journal-title":"Head Neck"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hed.20161","article-title":"Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group","volume":"27","author":"Yu","year":"2005","journal-title":"Head Neck"},{"key":"R7-5-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.cco.0000160276.78762.17","article-title":"18F-fluoro-2-deoxy-D-glucose positron emission tomographic imaging: recent developments in head and neck cancer","volume":"17","author":"Muylle","year":"2005","journal-title":"Curr Opin Oncol"},{"key":"R8-5-20210128","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2967\/jnumed.107.043406","article-title":"18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma","volume":"48","author":"Liu","year":"2007","journal-title":"J Nucl Med"},{"key":"R9-5-20210128","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijrobp.2004.09.057","article-title":"Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography","volume":"62","author":"Chang","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R10-5-20210128","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2007.11.002","article-title":"FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best?: a systematic review","volume":"85","author":"Liu","year":"2007","journal-title":"Radiother Oncol"},{"key":"R11-5-20210128","first-page":"855","article-title":"Comparison between PET-CT and MRI in diagnosing nodal metastasis of nasopharyngeal carcinoma","volume":"24","author":"Hu","year":"2005","journal-title":"Ai Zheng"},{"key":"R12-5-20210128","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ijrobp.2006.02.037","article-title":"Influence of [18F] fluorodeoxyglucose positron emission tomography on salvage treatment decision making for locally persistent nasopharyngeal carcinoma","volume":"65","author":"Zheng","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-5-20210128","first-page":"1471","article-title":"Clinical usefulness of fused PET\/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients","volume":"26","author":"Chen","year":"2006","journal-title":"Anticancer Res"},{"key":"R14-5-20210128","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijrobp.2006.12.028","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management","volume":"68","author":"Gordin","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-5-20210128","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1471-2407-6-283","article-title":"Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9","volume":"6","author":"Keryer-Bibens","year":"2006","journal-title":"BMC Cancer"},{"key":"R16-5-20210128","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMoa032260","article-title":"Quantification of plasma Epstein\u2013Barr virus DNA in patients with advanced nasopharyngeal carcinoma","volume":"350","author":"Lin","year":"2004","journal-title":"N Engl J Med"},{"key":"R17-5-20210128","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1200\/JCO.2006.07.7982","article-title":"Plasma Epstein\u2013Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma","volume":"24","author":"Leung","year":"2006","journal-title":"J Clin Oncol"},{"key":"R18-5-20210128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/1471-2407-6-259","article-title":"Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma","volume":"6","author":"Chan","year":"2006","journal-title":"BMC Cancer"},{"key":"R19-5-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jcp.2005.030544","article-title":"Role of Epstein\u2013Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area","volume":"59","author":"Kalpoe","year":"2006","journal-title":"J Clin Pathol"},{"key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00000421-200206000-00002","article-title":"Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma","volume":"25","author":"Huncharek","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"R21-5-20210128","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1200\/JCO.2004.10.074","article-title":"The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: A meta-analysis of the published literature","volume":"22","author":"Langendijk","year":"2004","journal-title":"J Clin Oncol"},{"key":"R22-5-20210128","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/cncr.20768","article-title":"Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma","volume":"103","author":"Ma","year":"2005","journal-title":"Cancer"},{"key":"R23-5-20210128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijrobp.2005.06.037","article-title":"Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients","volume":"64","author":"Baujat","year":"2006","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"R24-5-20210128","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1200\/JCO.2005.16.790","article-title":"Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer\/International Union Against Cancer Stage III and IV nasopharyngeal cancer of the endemic variety","volume":"23","author":"Wee","year":"2005","journal-title":"J Clin Oncol"},{"key":"R25-5-20210128","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1200\/JCO.2004.00.7542","article-title":"Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group","volume":"23","author":"Lee","year":"2005","journal-title":"J Clin Oncol"},{"key":"R26-5-20210128","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/cncr.22119","article-title":"The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy","volume":"107","author":"Kong","year":"2006","journal-title":"Cancer"},{"issue":"Suppl 10","key":"R27-5-20210128","first-page":"x39","article-title":"Chemo-radiotherapy in head and neck cancer","volume":"17","author":"Bourhis","year":"2006","journal-title":"Ann Oncol"},{"key":"R28-5-20210128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cncr.22396","article-title":"Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques","volume":"109","author":"Fang","year":"2007","journal-title":"Cancer"},{"key":"R29-5-20210128","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/annonc\/mdl090","article-title":"Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma","volume":"17","author":"Wong","year":"2006","journal-title":"Ann Oncol"},{"key":"R30-5-20210128","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"R31-5-20210128","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1200\/JCO.1988.6.9.1401","article-title":"Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in loco-regional nasopharyngeal cancer: Results of 4-year multicenter randomized study","volume":"6","author":"Rossi","year":"1988","journal-title":"J Clin Oncol"},{"key":"R32-5-20210128","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0360-3016(95)00218-N","article-title":"A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma","volume":"33","author":"Chan","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R33-5-20210128","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"key":"R34-5-20210128","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0360-3016(01)02781-X","article-title":"A phase III study of adjuvant chemotherapy in advanced stage nasopharyngeal carcinoma patients","volume":"52","author":"Chi","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R35-5-20210128","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0360-3016(96)80007-1","article-title":"Preliminary results of trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in Stage IV (\u2265N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression free survival","volume":"35","author":"Cvitkovic","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R36-5-20210128","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2270::AID-CNCR6>3.0.CO;2-T","article-title":"Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma","volume":"83","author":"Chua","year":"1998","journal-title":"Cancer"},{"key":"R37-5-20210128","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2001.19.5.1350","article-title":"Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma","volume":"19","author":"Ma","year":"2001","journal-title":"J Clin Oncol"},{"key":"R38-5-20210128","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/cncr.10473","article-title":"A prospective randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in advanced nasopharyngeal carcinoma","volume":"94","author":"Haeryama","year":"2002","journal-title":"Cancer"},{"key":"R39-5-20210128","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1200\/JCO.2005.12.081","article-title":"Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials","volume":"23","author":"Chua","year":"2005","journal-title":"J Clin Oncol"},{"key":"R40-5-20210128","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1200\/JCO.2002.07.011","article-title":"Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation","volume":"20","author":"Rischin","year":"2002","journal-title":"J Clin Oncol"},{"key":"R41-5-20210128","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/annonc\/mdg163","article-title":"Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer","volume":"14","author":"Oh","year":"2003","journal-title":"Ann Oncol"},{"key":"R42-5-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.2004.05.178","article-title":"A phase II study of neoadjuvant taxol and carboplatin followed by concurrent cisplatin-radiotherapy in locoregionally advanced nasopharyngeal carcinoma with EBV DNA monitoring","volume":"22","author":"Chan","year":"2004","journal-title":"J Clin Oncol"},{"key":"R43-5-20210128","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"R44-5-20210128","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"R46-5-20210128","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/cncr.20804","article-title":"Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a phase II trial using a triplet combination","volume":"103","author":"Leong","year":"2005","journal-title":"Cancer"},{"key":"R48-5-20210128","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1200\/JCO.2000.18.6.1324","article-title":"Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type","volume":"18","author":"Fandi","year":"2000","journal-title":"J Clin Oncol"},{"key":"R49-5-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/030089160208800405","article-title":"Carboplatin plus taxol is an effective third line regimen in recurrent undifferentiated nasopharyngeal carcinoma","volume":"88","author":"Airoldi","year":"2002","journal-title":"Tumori"},{"key":"R50-5-20210128","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1368-8375(02)00120-3","article-title":"A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy","volume":"39","author":"Chua","year":"2003","journal-title":"Oral Oncol"},{"key":"R51-5-20210128","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/annonc\/mdl175","article-title":"Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer","volume":"18","author":"Cruz","year":"2007","journal-title":"Ann Oncol"},{"key":"R53-5-20210128","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2006.10.2871","article-title":"Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma","volume":"25","author":"Elser","year":"2007","journal-title":"J Clin Oncol"},{"key":"R54-5-20210128","first-page":"185","article-title":"Role of Epstein\u2013Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma","volume":"4","author":"Zheng","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"R55-5-20210128","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1182\/blood-2004-07-2975","article-title":"Treatment of nasopharyngeal carcinoma with Epstein\u2013Barr virus-specific T lymphocytes","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCO.0b013e3282fad846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:14:08Z","timestamp":1786040048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001622-200805000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0b013e3282fad846","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}